Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity of Multiple Doses of ALG-000184 in Healthy Volunteers (HV) and Subjects with Chronic Hepatitis B (CHB)

ALIGOS_Poster.jpg

ATI-2173, a novel active site polymerase inhibitor nucleotide (ASPIN), for HBV cure regimens is well tolerated and has favorable pharmacokinetics in healthy volunteers

ANTIOS_Poster.jpg